Covidien Redefines Surgical Stapling with
Introduction of New Tri-Staple™ Technology
New generation of endoscopic stapling technology offers outstanding clinical performance in wider range of
laparoscopic surgical procedures
June 23, 2010 06:03 AM Eastern Daylight Time
NORTH HAVEN, Conn.--(EON: Enhanced Online News)--Covidien (NYSE: COV), a leading global provider of
healthcare products, today announced the worldwide launch of its proprietary Tri-Staple™ technology platform for
endoscopic stapling. The first-of-its-kind technology enables surgeons to use staplers in a wider variety of
laparoscopic procedures and in a broader range of tissue thicknesses than ever before.
In the initial phase of the launch, Covidien today is introducing the Endo GIA™ Reloads with Tri-Staple technology
and the Endo GIA™ Ultra Universal stapler at the 27th Annual Meeting of the American Society of Metabolic &
Bariatric Surgeons (ASMBS) in Las Vegas, Nevada. Over the course of the next 12 months, Covidien will launch
additional stapling products developed with this new technology.
The new Endo GIA stapling system includes an ergonomically enhanced, lightweight handle designed for precise
control. The easy-to-use stapling solution features unique reloads using Tri-Staple technology to deliver outstanding
performance across a wider range of tissue thicknesses. The end result is simplified cartridge selection, a new
grasping feature for improved tissue maneuverability, advanced compression for increased tissue stability and
significantly less force needed for firing.
“One limitation of conventional endoscopic staplers is that the surgeon has to choose from multiple cartridge sizes to
ensure an ideal staple line for every type of tissue. Also, significant force has to be applied to squeeze the handle that
advances the knife blade in each firing, which can lead to fatigue after several procedures,” said Dr. Aurora Pryor,
Associate Professor, Duke University Medical Center. “The new En